ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,467.46
      0.95%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BiondVax Pharmaceuticals Ltd (BVXV)

      7. BiondVax Pharmaceuticals Ltd (BVXV) News

      BVXV

      BiondVax Pharmaceuticals (BVXV)

      BiondVax Pharmaceuticals Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BVXV
      DateTimeSourceHeadlineSymbolCompany
      11/18/20197:15AMPR Newswire (US)Enrollment and Randomization of 12,463 Participants Complete in BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu ...NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/12/20196:09AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      10/08/20196:03AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      10/07/20199:15AMPR Newswire (US)BiondVax Receives €4M From the European Investment Bank (EIB) in Support of Ongoing Universal Influenza Vaccine Pivotal Pha...NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      08/28/201910:51AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      08/28/20197:45AMPR Newswire (US)BiondVax Welcomes New Chairman of the Board and Announces Second Quarter 2019 Financial ResultsNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      07/16/201910:25AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      07/16/20197:30AMPR Newswire (US)BiondVax Announces Rights Offering Fully Subscribed at US$20 MillionNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      07/08/20198:30AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      07/08/20197:52AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      07/08/20195:46AMPR Newswire (US)First Participant Enrolled in Second Cohort of BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine TrialNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/26/201910:51AMPR Newswire (US)European Investment Bank VP Attends Signature Event at BiondVax Extending Financing Agreement With BiondVax to €24millionNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/18/20199:23AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/18/20196:30AMPR Newswire (US)Patent Covering Manufacturing Process of BiondVax's M-001 Universal Flu Vaccine Allowed in USA and JapanNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/11/20196:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/10/20198:18AMPR Newswire (US)BiondVax Announces Rights Offering in Support of Ongoing Pivotal, Clinical Efficacy Phase 3 Trial of the M-001 Universal Flu ...NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/07/201911:44AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/06/20196:04AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/30/20199:47AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/30/20198:47AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/30/20197:10AMPR Newswire (US)BiondVax Announces First Quarter 2019 Financial ResultsNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/29/20196:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/15/20197:51AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/13/20197:00AMPR Newswire (US)BiondVax to Provide Update of M-001 Universal Flu Vaccine Pivotal Phase 3 Clinical Trial at 18th MIXiii-BIOMED ConferenceNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/06/201910:03AMEdgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/01/20196:48AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      04/30/20194:01PMPR Newswire (US)BiondVax Announces Fourth Quarter and Full Year 2018 Financial Results and UpdateNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      04/30/20196:34AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      04/23/20196:19AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      04/22/201910:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
       Showing the most relevant articles for your search:NASDAQ:BVXV